Evidence map›Paper›PMID 35045668›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2021

[Health-related quality of life and its associated variables in Chinese patients with Philadelphia-negative myeloproliferative neoplasms].

M Bao, D Y Shi, H X Shi, X L Liu, M H Duan, J L Zhuang, X Du, L Qin, W H Hui, R Liang and 20 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 73% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 13 institutions in 1 country.

M BaoPeking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China.
D Y ShiPeking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China.
H X ShiPeking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China.
X L LiuNanfang Hospital, Southern Medical University, Guangzhou 510080, China.
M H DuanPeking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
J L ZhuangPeking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
X DuThe Second People's Hospital of Shenzhen, Shenzhen 518035, China.
L QinThe First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Zhengzhou 471003, China.
W H HuiXuanwu Hospital, Capital Medical University, Beijing 100053, China.
R LiangXi Jing Hospital, The Fourth Military Medical University, Xi An 710032, China.
M F WangSecond Hospital of Shanxi Medical University, Taiyuan 030001, China.
Y ChenBeijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
D Y LiDongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China.
W YangShengjing Hospital Affiliated to China Medical University, Shenyang 110020, China.
G S TangDepartment of Hematology, Institute of Hematology, The First Affiliated Hospital of Naval Medical University, Changhai Hospital, Shanghai 200433, China.
W H ZhangDepartment of Hematology, First Hospital of Shanxi Medical University, Taiyuan 300012, China.
X KuangKaifeng Central Hospital, Kaifeng 475000, China.
W SuDongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China.
Y Q HanThe Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, China.
L M ChenThe First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
J H XuDepartment of Hematology, Qiqihar First Hospital, Qiqihar 161005, China.
Z G LiuShengjing Hospital Affiliated to China Medical University, Shenyang 110020, China.
J HuangDepartment of Hematology, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 322000, China.
C T ZhaoDepartment of Hematology, The Affiliated Hospital of Qingdao University, Qingdao 266003, China.
H Y TongDepartment of Hematology, The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou 310003, China.
J D HuDepartment of Hematology, Fujian Medical University Union Hospital, Fuzhou 350001, China.
C Y ChenDepartment of Hematology, Shandong University Qilu Hospital, Jinan 250012, China.
X Q ChenInstitute of Hematology & Affiliated Hospital, Medicine School, Northwestern University, Xi'an 710069, China.
Z J XiaoInstitute of Hematology and Blood Diseases Hospital, CAMS & PUMC, National Clinical Research Center for Blood Diseases, The State Key Laboratory of Experimental Hematology, Tianjin 300020, China.
Q JiangPeking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China.
Peking University · CNAffiliated Hospital of Qingdao University · CNBeijing Anzhen Hospital · CNBeijing University of Chinese Medicine · CNCapital Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNDongzhimen Hospital Affiliated to Beijing University of Chinese Medicine · CNFirst Affiliated Hospital of Xi'an Jiaotong University · CNInner Mongolia Medical University · CNPeking Union Medical College Hospital · CNPeking University People's Hospital · CNShanxi Medical University · CNShenzhen Second People's Hospital · CN

Funding

National Natural Science Foundation of China 81770161, 81970140
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Myeloproliferative DisordersPolycythemia VeraAdultChinaCross-Sectional StudiesHumansMaleMiddle AgedQuality of LifeSurveys and QuestionnairesHealth-related quality of lifeMyeloproliferative neoplasmsSymptom burden

Identifiers

PMID35045668
PMCPMC8770887
OpenAlexW4205735272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.